AI Medical Service Inc. Signs Joint Research Agreement with US Leading Cancer Institution
(hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Memorial Sloan Kettering Cancer Center (MSK), one of the world’s top medical research institutes on July 27, 2023.
- (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Memorial Sloan Kettering Cancer Center (MSK), one of the world’s top medical research institutes on July 27, 2023.
- AIM is the first Japanese company*1 to sign a joint research agreement with MSK in the field of gastrointestinal endoscopy AI.
- Its collaboration with MSK will facilitate joint research to investigate the application of Japanese gastrointestinal endoscopy AI in the United States.
- Comment from CEO of AIM, Dr. Tomohiro Tada
"I am very pleased that we have established a joint research agreement with Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading cancer research centers.